Legal & General Group’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-123,250
Closed -$660K 3398
2025
Q3
$660K Hold
123,250
﹤0.01% 2363
2025
Q2
$661K Buy
123,250
+8,411
+7% +$33.4K ﹤0.01% 2367
2025
Q1
$320K Hold
114,839
﹤0.01% 2532
2024
Q4
$359K Buy
114,839
+3,314
+3% +$9.55K ﹤0.01% 2569
2024
Q3
$344K Hold
111,525
﹤0.01% 2576
2024
Q2
$370K Buy
+111,525
New +$365K ﹤0.01% 2530
2023
Q2
Sell
-23,158
Closed -$161K 3439
2023
Q1
$161K Hold
23,158
﹤0.01% 2656
2022
Q4
$140K Hold
23,158
﹤0.01% 2730
2022
Q3
$182K Hold
23,158
﹤0.01% 2660
2022
Q2
$315K Sell
23,158
-6,975
-23% -$115K ﹤0.01% 2469
2022
Q1
$591K Buy
30,133
+74
+0.2% +$1.48K ﹤0.01% 2351
2021
Q4
$1.03M Buy
30,059
+249
+0.8% +$10K ﹤0.01% 2231
2021
Q3
$1.63M Sell
29,810
-1,160
-4% -$69.9K ﹤0.01% 2108
2021
Q2
$2.27M Sell
30,970
-8,786
-22% -$878K ﹤0.01% 1911
2021
Q1
$3.64M Buy
+39,756
New +$3.86M ﹤0.01% 1728

Other funds holding CVAC

Legal & General Group's CVAC Position: Q4 2025 in Review

Legal & General Group sold out of CureVac (CVAC) in Q4 2025, closing a stake of 123,250 shares — an estimated $660K sold.

Legal & General Group first reported a position in CVAC in Q1 2021 and held it in 15 quarters. The position peaked at $3.64M in Q1 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Legal & General Group reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Legal & General Group sold 123,250 CureVac shares in Q4 2025, an estimated $660K.
  • Legal & General Group first reported a position in CureVac in Q1 2021 and held it in 15 quarters.
  • Legal & General Group's CureVac position peaked at $3.64M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Legal & General Group's 13F filing for Q4 2025, filed 9 Feb 2026.